Biotechnology Stocks
244 US-listed companies in the Biotechnology industry, part of the Healthcare sector, ranked by market capitalisation. Open any ticker for quotes, charts, financials and analyst ratings.
Companies
244
Market cap
1.26T
P/E
18.4
Div yield
7.69%
Perf 1M
-0.29%
Perf YTD
34.88%
All 244 Biotechnology stocks
| Ticker | Company | Price | Change | Market cap | P/E | Perf YTD |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 530.53 | 6.95% | 125.91B | 28.6 | 9.42% |
| REGN | Regeneron Pharmaceuticals, Inc. | 796.36 | 1.53% | 80.81B | 18.7 | 1.62% |
| ARGX | argenx SE | 886.57 | 2.49% | 54.86B | 32.0 | 2.86% |
| ONC | BeOne Medicines AG | 357.43 | 2.63% | 46.39B | 5.5 | 14.63% |
| RVMD | Revolution Medicines, Inc. | 205.74 | 0.29% | 43.61B | — | 157.56% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 218.24 | -0.44% | 29.33B | 35.9 | -44.88% |
| INSM | Insmed Incorporated | 133.42 | 1.77% | 28.42B | — | -24.67% |
| ROIV | Roivant Sciences Ltd. | 36.31 | -0.08% | 26.25B | — | 67.47% |
| INCY | Incyte Corporation | 122.28 | 1.43% | 24.44B | 14.8 | 22.06% |
| MRNA | Moderna, Inc. | 59.67 | 0.84% | 23.48B | — | 100.64% |
| BNTX | BioNTech SE | 93.71 | 0.05% | 23.09B | — | -1.61% |
| UTHR | United Therapeutics Corporation | 530.97 | -1.46% | 22.87B | 17.8 | 10.59% |
| GMAB | Genmab A/S | 30.95 | -0.94% | 18.98B | 23.2 | 1.46% |
| BBIO | BridgeBio Pharma, Inc. | 85.26 | 0.92% | 16.55B | — | 10.45% |
| NBIX | Neurocrine Biosciences, Inc. | 164.20 | 0.48% | 16.43B | 23.2 | 15.22% |
| JAZZ | Jazz Pharmaceuticals plc | 258.18 | 0.63% | 16.12B | 16.9 | 50.92% |
| ASND | Ascendis Pharma A/S | 254.55 | -0.34% | 15.87B | 27.0 | 19.78% |
| EXEL | Exelixis, Inc. | 53.09 | -1.80% | 13.59B | 16.4 | 23.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 88.23 | 0.66% | 12.35B | — | 32.02% |
| BMRN | BioMarin Pharmaceutical Inc. | 65.53 | 2.69% | 12.33B | 167.9 | 7.37% |
| HALO | Halozyme Therapeutics, Inc. | 101.24 | -1.82% | 12.23B | 29.3 | 53.22% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 515.62 | 1.09% | 11.78B | — | -12.42% |
| TECH | Bio-Techne Corporation | 72.22 | -0.09% | 11.32B | 101.8 | 22.92% |
| SMMT | Summit Therapeutics Inc. | 14.69 | 5.19% | 11.14B | — | -20.18% |
| AXSM | Axsome Therapeutics, Inc. | 217.03 | 2.02% | 10.95B | — | 16.48% |
| PRAX | Praxis Precision Medicines, Inc. | 359.71 | -0.29% | 10.06B | — | 22.40% |
| ABVX | Abivax S.A. | 128.75 | -1.67% | 9.69B | — | -2.91% |
| KRYS | Krystal Biotech, Inc. | 329.13 | 0.82% | 9.62B | 39.5 | 32.41% |
| CYTK | Cytokinetics, Incorporated | 76.57 | -0.25% | 9.55B | — | 20.81% |
| IONS | Ionis Pharmaceuticals, Inc. | 57.40 | 1.49% | 9.40B | — | -28.50% |
| PTGX | Protagonist Therapeutics, Inc. | 148.69 | 1.94% | 9.38B | 119.8 | 67.01% |
| NUVL | Nuvalent, Inc. | 123.96 | 0.00% | 9.13B | — | 23.23% |
| SYRE | Spyre Therapeutics, Inc. | 105.10 | 0.18% | 9.11B | — | 220.24% |
| CRNX | Crinetics Pharmaceuticals, Inc. | 84.23 | 0.18% | 8.91B | — | 80.62% |
| KYMR | Kymera Therapeutics, Inc. | 108.54 | 0.95% | 8.84B | — | 38.18% |
| PCVX | Vaxcyte, Inc. | 59.12 | 1.80% | 8.39B | — | 25.86% |
| APGE | Apogee Therapeutics, Inc. | 134.65 | -0.14% | 8.34B | — | 78.64% |
| ALKS | Alkermes plc | 49.00 | -0.34% | 8.25B | 122.0 | 75.73% |
| IMVT | Immunovant, Inc. | 39.70 | -0.63% | 8.25B | — | 57.16% |
| IBRX | ImmunityBio, Inc. | 7.57 | -0.98% | 8.00B | — | 285.86% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 115.75 | 0.10% | 7.93B | — | 8.03% |
| TGTX | TG Therapeutics, Inc. | 49.38 | -0.75% | 7.62B | 16.3 | 66.92% |
| COGT | Cogent Biosciences, Inc. | 41.84 | -1.29% | 7.24B | — | 19.34% |
| CGON | CG Oncology Inc. | 75.78 | 0.91% | 6.62B | — | 80.88% |
| BLTE | Belite Bio, Inc | 165.46 | 1.48% | 6.54B | — | 1.93% |
| CAI | Caris Life Sciences, Inc. | 22.96 | 0.98% | 6.43B | 61.1 | -15.72% |
| ERAS | Erasca, Inc. | 18.05 | -1.96% | 6.39B | — | 394.89% |
| SRRK | Scholar Rock Holding Corporation | 51.42 | -2.83% | 6.34B | — | 20.14% |
| CNTA | Centessa Pharmaceuticals plc | 40.50 | 0.00% | 6.27B | — | 61.94% |
| MIRM | Mirum Pharmaceuticals, Inc. | 98.92 | -1.72% | 6.14B | — | 27.42% |
| XENE | Xenon Pharmaceuticals Inc. | 63.28 | -0.13% | 6.12B | — | 41.37% |
| PTCT | PTC Therapeutics, Inc. | 73.98 | 0.91% | 6.12B | — | -3.49% |
| ORKA | Oruka Therapeutics, Inc. | 103.96 | 5.20% | 5.96B | — | 226.03% |
| LGND | Ligand Pharmaceuticals Incorporated | 290.67 | -0.85% | 5.88B | 29.3 | 55.05% |
| TVTX | Travere Therapeutics, Inc. | 62.20 | 1.43% | 5.70B | — | 60.48% |
| CRSP | CRISPR Therapeutics AG | 54.09 | 1.07% | 5.16B | — | 2.06% |
| DFTX | Definium Therapeutics, Inc. | 44.51 | -3.53% | 5.03B | — | 244.59% |
| ACAD | ACADIA Pharmaceuticals Inc. | 29.46 | 0.85% | 5.00B | 13.0 | 9.36% |
| DYN | Dyne Therapeutics, Inc. | 26.40 | 0.57% | 4.90B | — | 34.20% |
| MANE | Veradermics, Incorporated | 109.21 | -4.53% | 4.78B | — | 236.44% |
| EWTX | Edgewise Therapeutics, Inc. | 43.63 | 0.25% | 4.68B | — | 75.34% |
| DNTH | Dianthus Therapeutics, Inc. | 109.72 | 0.73% | 4.55B | — | 164.30% |
| CELC | Celcuity Inc. | 92.17 | -0.66% | 4.52B | — | -6.98% |
| ELVN | Enliven Therapeutics, Inc. | 59.72 | -1.22% | 4.32B | — | 292.60% |
| PRTC | PureTech Health plc | 17.38 | 4.51% | 4.23B | — | 4.45% |
| VKTX | Viking Therapeutics, Inc. | 34.57 | 0.90% | 4.00B | — | -2.62% |
| ADPT | Adaptive Biotechnologies Corporation | 25.75 | 3.29% | 3.99B | — | 53.51% |
| DNLI | Denali Therapeutics Inc. | 24.69 | -0.57% | 3.94B | — | 50.39% |
| TLX | Telix Pharmaceuticals Limited | 11.81 | 2.56% | 3.88B | — | 53.81% |
| CPRX | Catalyst Pharmaceuticals, Inc. | 31.49 | 0.00% | 3.85B | 17.5 | 34.92% |
| LEGN | Legend Biotech Corporation | 20.80 | 0.24% | 3.84B | — | -4.55% |
| RCUS | Arcus Biosciences, Inc. | 28.72 | 0.35% | 3.60B | — | 20.10% |
| IDYA | IDEAYA Biosciences, Inc. | 37.12 | 0.27% | 3.52B | — | 7.09% |
| RLAY | Relay Therapeutics, Inc. | 20.30 | 2.68% | 3.46B | — | 133.69% |
| ALMS | Alumis Inc. | 27.30 | -1.09% | 3.41B | — | 182.79% |
| TNGX | Tango Therapeutics, Inc. | 27.43 | 1.33% | 3.37B | — | 205.53% |
| NAMS | NewAmsterdam Pharma Company N.V. | 28.07 | 0.38% | 3.27B | — | -20.30% |
| MBX | MBX Biosciences, Inc. Common Stock | 66.24 | -2.33% | 3.23B | — | 115.03% |
| QURE | uniQure N.V. | 46.08 | -0.73% | 3.22B | — | 93.98% |
| ARQT | Arcutis Biotherapeutics, Inc. | 25.75 | 1.82% | 3.16B | 114.5 | -12.91% |
| GPCR | Structure Therapeutics Inc. | 52.73 | -0.78% | 3.06B | — | -23.59% |
| GRAL | GRAIL Inc. | 74.96 | 7.89% | 2.98B | — | -18.82% |
| IRON | Disc Medicine, Inc. | 77.69 | 0.32% | 2.97B | — | -2.48% |
| KOD | Kodiak Sciences Inc. | 44.35 | -2.25% | 2.84B | — | 62.27% |
| IOVA | Iovance Biotherapeutics, Inc. | 6.44 | 1.58% | 2.83B | — | 132.23% |
| BEAM | Beam Therapeutics Inc. | 27.49 | 0.04% | 2.83B | — | -0.87% |
| TARS | Tarsus Pharmaceuticals, Inc. | 65.25 | 0.70% | 2.79B | — | -20.87% |
| CLDX | Celldex Therapeutics, Inc. | 42.71 | 2.40% | 2.78B | — | 53.57% |
| ATAI | Atai Beckley Inc. | 7.25 | -0.07% | 2.68B | — | 77.26% |
| NRIX | Nurix Therapeutics, Inc. | 25.75 | 0.88% | 2.65B | — | 34.58% |
| TRVI | Trevi Therapeutics, Inc. | 18.00 | -2.76% | 2.63B | — | 47.84% |
| PGEN | Precigen, Inc. | 7.23 | 0.00% | 2.58B | — | 72.97% |
| RARE | Ultragenyx Pharmaceutical Inc. | 26.36 | 1.76% | 2.55B | — | 12.65% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 22.51 | -1.34% | 2.54B | — | 88.91% |
| ZLAB | Zai Lab Limited | 23.50 | 0.77% | 2.48B | — | 32.20% |
| PHVS | Pharvaris N.V. | 34.66 | -0.72% | 2.44B | — | 25.80% |
| KLRA | Kailera Therapeutics, Inc. | 18.75 | 0.48% | 2.42B | — | -28.23% |
| MLYS | Mineralys Therapeutics, Inc. | 27.35 | 0.00% | 2.41B | — | -24.63% |
| IMNM | Immunome, Inc. | 25.93 | 3.60% | 2.39B | — | 16.53% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 9.63 | 2.72% | 2.38B | — | 20.26% |
| VERA | Vera Therapeutics, Inc. | 32.16 | -2.22% | 2.36B | — | -35.05% |
| VCEL | Vericel Corporation | 44.58 | -1.13% | 2.31B | 93.9 | 25.22% |
| SION | Sionna Therapeutics, Inc. | 4.11 | -91.96% | 2.30B | — | 24.06% |
| ADMA | ADMA Biologics, Inc. | 9.93 | 0.25% | 2.29B | 13.8 | -45.72% |
| NUVB | Nuvation Bio Inc. | 6.54 | -0.76% | 2.29B | — | -26.34% |
| URGN | UroGen Pharma Ltd. | 46.46 | -1.06% | 2.29B | — | 100.51% |
| PVLA | Palvella Therapeutics, Inc. | 155.46 | -1.46% | 2.26B | — | 50.73% |
| SLS | SELLAS Life Sciences Group, Inc. | 11.68 | -2.75% | 2.23B | — | 218.57% |
| HRMY | Harmony Biosciences Holdings, Inc. | 39.15 | 1.93% | 2.22B | 12.3 | 2.65% |
| BHVN | Biohaven Ltd. | 14.83 | 1.16% | 2.21B | — | 29.85% |
| NKTR | Nektar Therapeutics | 75.46 | -1.33% | 2.19B | — | 80.89% |
| RAPP | Rapport Therapeutics, Inc. Common Stock | 46.58 | 2.40% | 2.18B | — | 49.93% |
| VRDN | Viridian Therapeutics, Inc. | 23.26 | -1.42% | 2.12B | — | -24.20% |
| ABCL | AbCellera Biologics Inc. | 9.16 | 32.25% | 2.12B | — | 102.63% |
| STOK | Stoke Therapeutics, Inc. | 32.38 | -1.01% | 2.11B | — | 3.06% |
| TSHA | Taysha Gene Therapies, Inc. | 6.52 | -0.67% | 2.10B | — | 19.27% |
| GHRS | GH Research PLC | 29.71 | -1.85% | 2.08B | — | 138.35% |
| ZBIO | Zenas BioPharma, Inc. | 32.17 | -0.80% | 2.05B | — | -10.69% |
| MESO | Mesoblast Limited | 16.73 | 4.92% | 2.04B | — | -11.64% |
| AUPH | Aurinia Pharmaceuticals Inc. | 15.49 | -2.24% | 2.04B | 6.7 | -0.63% |
| OCUL | Ocular Therapeutix, Inc. | 9.26 | 0.71% | 2.01B | — | -24.30% |
| NBTX | Nanobiotix S.A. | 37.03 | -3.11% | 1.97B | — | 65.31% |
| AGIO | Agios Pharmaceuticals, Inc. | 32.76 | 1.52% | 1.93B | — | 18.55% |
| DMRA | Damora Therapeutics, Inc. | 29.87 | -0.17% | 1.84B | — | 30.03% |
| GENB | Generate Biomedicines, Inc. | 14.49 | 0.98% | 1.84B | — | -4.33% |
| CMPS | COMPASS Pathways plc | 13.22 | -2.36% | 1.83B | — | 96.23% |
| SNDX | Syndax Pharmaceuticals, Inc. | 20.57 | 0.81% | 1.81B | — | -2.90% |
| LKFT | Lakefront Biotherapeutics N.V. | 26.92 | -0.30% | 1.78B | 3.1 | -17.43% |
| SRPT | Sarepta Therapeutics, Inc. | 16.67 | -0.66% | 1.77B | — | -22.03% |
| AAPG | Ascentage Pharma Group International | 18.69 | -1.55% | 1.77B | — | -27.63% |
| FTRE | Fortrea Holdings Inc. | 18.70 | 1.49% | 1.75B | — | 6.84% |
| SEPN | Septerna Inc | 39.17 | 0.88% | 1.75B | — | 39.28% |
| ZYME | Zymeworks Inc. | 24.05 | 2.17% | 1.73B | — | -10.60% |
| IMCR | Immunocore Holdings plc | 34.13 | 0.38% | 1.73B | — | -2.05% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 6.14 | -1.43% | 1.72B | — | 91.69% |
| RXRX | Recursion Pharmaceuticals, Inc. | 3.31 | 2.71% | 1.69B | — | -21.27% |
| ANAB | AnaptysBio, Inc. | 57.08 | 0.83% | 1.68B | — | 75.15% |
| MAZE | Maze Therapeutics, Inc. | 26.98 | -5.85% | 1.59B | — | -30.85% |
| TRAX | First Tracks Biotherapeutics Inc | 46.96 | 3.60% | 1.58B | — | 121.01% |
| TYRA | Tyra Biosciences, Inc. | 26.26 | -0.94% | 1.58B | — | 0.84% |
| XNCR | Xencor, Inc. | 21.34 | 2.55% | 1.54B | — | 35.92% |
| BCAX | Bicara Therapeutics Inc. Common Stock | 28.14 | 0.30% | 1.54B | — | 66.73% |
| MLTX | MoonLake Immunotherapeutics | 17.35 | -5.00% | 1.54B | — | 38.54% |
| INVA | Innoviva, Inc. | 20.65 | 0.68% | 1.51B | 4.2 | 2.60% |
| ABSI | Absci Corporation | 9.16 | 2.63% | 1.51B | — | 155.87% |
| AVLN | Avalyn Pharma Inc. Common Stock | 33.39 | -1.56% | 1.50B | — | 30.46% |
| VIR | Vir Biotechnology, Inc. | 9.01 | 2.10% | 1.49B | — | 46.27% |
| KALV | KalVista Pharmaceuticals, Inc. | 27.00 | 0.00% | 1.44B | — | 67.18% |
| AVBP | ArriVent BioPharma, Inc. | 30.85 | 0.03% | 1.44B | — | 53.28% |
| ORIC | ORIC Pharmaceuticals, Inc. | 13.26 | -1.78% | 1.40B | — | 65.04% |
| LBRX | LB Pharmaceuticals Inc Common Stock | 46.16 | -3.83% | 1.38B | — | 115.63% |
| XERS | Xeris Biopharma Holdings, Inc. | 8.04 | 1.32% | 1.37B | — | 1.02% |
| GLUE | Monte Rosa Therapeutics, Inc. | 15.90 | 0.13% | 1.34B | — | 1.28% |
| NTLA | Intellia Therapeutics, Inc. | 12.10 | 1.34% | 1.34B | — | 32.81% |
| MNKD | MannKind Corporation | 3.95 | -3.89% | 1.31B | — | -27.51% |
| NVAX | Novavax, Inc. | 7.87 | -1.01% | 1.31B | — | 18.30% |
| INBX | Inhibrx Biosciences Inc. | 90.01 | 1.52% | 1.30B | — | 12.23% |
| IMTX | Immatics N.V. | 9.73 | 0.83% | 1.29B | — | -8.10% |
| AKTS | Aktis Oncology, Inc. | 24.58 | 1.87% | 1.29B | — | -10.63% |
| SPTX | Seaport Therapeutics, Inc. Common Stock | 23.58 | -0.16% | 1.26B | — | 12.48% |
| MGTX | MeiraGTx Holdings plc | 13.18 | 0.84% | 1.21B | — | 64.40% |
| WVE | Wave Life Sciences Ltd. | 6.09 | -0.16% | 1.20B | — | -64.12% |
| SVRA | Savara Inc. | 5.78 | -0.79% | 1.19B | — | -3.32% |
| CRVS | Corvus Pharmaceuticals, Inc. | 13.60 | -2.30% | 1.17B | — | 80.78% |
| EYPT | EyePoint Pharmaceuticals, Inc. | 13.59 | -2.16% | 1.16B | — | -23.97% |
| LXRX | Lexicon Pharmaceuticals, Inc. | 2.40 | -2.65% | 1.10B | — | 114.78% |
| CGEM | Cullinan Therapeutics, Inc. | 18.24 | 2.90% | 1.09B | — | 71.30% |
| OLMA | Olema Pharmaceuticals, Inc. | 12.13 | 0.66% | 1.05B | — | -51.80% |
| OPK | OPKO Health, Inc. | 1.39 | 1.46% | 1.02B | — | 8.73% |
| REPL | Replimune Group, Inc. | 13.71 | 13.68% | 1.01B | — | 24.07% |
| ANRO | Alto Neuroscience, Inc. | 28.01 | -2.30% | 1.01B | — | 61.07% |
| ARDX | Ardelyx, Inc. | 4.00 | 0.13% | 988.12M | — | -31.39% |
| SANA | Sana Biotechnology, Inc. | 3.68 | 4.51% | 979.59M | — | -13.51% |
| JANX | Janux Therapeutics, Inc. | 16.59 | 4.66% | 966.60M | — | 14.86% |
| OMER | Omeros Corporation | 13.26 | 0.08% | 958.97M | 10.2 | -22.88% |
| GERN | Geron Corporation | 1.50 | 1.35% | 949.45M | — | 12.12% |
| ABUS | Arbutus Biopharma Corp | 4.63 | -0.10% | 914.60M | 5.6 | -3.74% |
| ANNX | Annexon, Inc. | 5.45 | 0.65% | 886.39M | — | 7.77% |
| TBPH | Theravance Biopharma Inc | 16.90 | -0.18% | 877.45M | 7.5 | -9.51% |
| DSGN | Design Therapeutics, Inc. | 14.20 | 1.51% | 873.77M | — | 49.15% |
| KURA | Kura Oncology, Inc. | 9.61 | 0.42% | 849.57M | — | -7.89% |
| SGP | SpyGlass Pharma, Inc. Common Stock | 25.11 | -0.81% | 846.20M | — | 5.46% |
| AURA | Aura Biosciences, Inc. | 7.74 | -3.16% | 826.46M | — | 46.61% |
| SLDB | Solid Biosciences Inc. | 8.51 | 1.43% | 825.99M | — | 48.76% |
| ACRS | Aclaris Therapeutics, Inc. | 5.75 | -2.79% | 825.41M | — | 96.35% |
| CLYM | Climb Bio, Inc. | 13.58 | -3.00% | 801.68M | — | 250.00% |
| MNPR | Monopar Therapeutics Inc. | 115.65 | -2.99% | 798.59M | — | 82.56% |
| PHAR | Pharming Group N.V. | 10.90 | -0.46% | 785.42M | 75.5 | -38.03% |
| DRUG | Bright Minds Biosciences Inc. | 78.77 | -0.70% | 779.70M | — | 1.65% |
| CADL | Candel Therapeutics, Inc. | 10.46 | -1.18% | 775.93M | — | 87.43% |
| CTMX | CytomX Therapeutics, Inc. | 3.43 | -0.87% | 753.25M | — | -18.78% |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 9.36 | 0.32% | 747.40M | — | -25.48% |
| RIGL | Rigel Pharmaceuticals, Inc. | 41.06 | 2.21% | 743.23M | 2.3 | -6.21% |
| OCS | Oculis Holding AG | 12.75 | 0.53% | 725.23M | — | -36.50% |
| JBIO | Jade Biosciences, Inc. | 22.34 | 1.73% | 716.46M | — | 42.32% |
| AGMB | AgomAb Therapeutics N.V. American Depositary Shares | 14.92 | 2.90% | 714.19M | — | -1.36% |
| ANL | Adlai Nortye Ltd. | 13.10 | -1.37% | 704.90M | — | 835.21% |
| ALLO | Allogene Therapeutics, Inc. | 2.07 | 2.99% | 693.76M | — | 46.72% |
| PHAT | Phathom Pharmaceuticals, Inc. | 8.48 | -0.82% | 691.70M | — | -48.46% |
| ZVRA | Zevra Therapeutics, Inc. | 11.30 | -2.23% | 683.37M | 12.0 | 29.02% |
| ACHV | Achieve Life Sciences, Inc. | 6.72 | 1.05% | 682.68M | — | 33.80% |
| ESPR | Esperion Therapeutics, Inc. | 3.18 | 0.00% | 661.15M | — | -14.05% |
| ODTX | Odyssey Therapeutics, Inc. | 21.50 | 1.58% | 639.94M | — | 5.85% |
| MDXG | MiMedx Group, Inc. | 4.25 | -2.19% | 632.60M | 108.5 | -35.89% |
| CBIO | Crescent Biopharma, Inc. | 17.38 | 3.21% | 625.50M | — | 41.99% |
| SPRY | ARS Pharmaceuticals, Inc. | 5.94 | -3.62% | 611.71M | — | -47.12% |
| GYRE | Gyre Therapeutics, Inc. | 6.57 | -1.50% | 609.58M | — | -5.52% |
| TECX | Tectonic Therapeutic, Inc. | 30.44 | -1.74% | 584.57M | — | 48.51% |
| CRMD | CorMedix Inc. | 7.37 | -0.94% | 583.68M | 3.1 | -36.03% |
| CTNM | Contineum Therapeutics, Inc. | 14.71 | -2.16% | 565.82M | — | 31.58% |
| ARVN | Arvinas, Inc. | 8.98 | 2.62% | 564.56M | 46.1 | -26.22% |
| SLN | Silence Therapeutics plc | 16.33 | 36.65% | 564.45M | — | 96.55% |
| NGNE | Neurogene Inc. | 35.93 | 0.67% | 563.99M | — | 73.25% |
| FDMT | 4D Molecular Therapeutics, Inc. | 11.22 | 4.41% | 561.97M | — | 43.33% |
| AUTL | Autolus Therapeutics plc | 2.15 | 1.66% | 561.56M | — | 6.03% |
| PRME | Prime Medicine, Inc. | 3.19 | 3.73% | 556.30M | — | -11.24% |
| RGNX | REGENXBIO Inc. | 10.60 | -1.11% | 554.20M | — | -25.56% |
| PROK | ProKidney Corp. | 1.67 | 1.83% | 551.46M | — | -26.79% |
| IMMX | Immix Biopharma, Inc. | 10.21 | 5.04% | 528.79M | — | 85.85% |
| DNA | Ginkgo Bioworks Holdings, Inc. | 8.12 | 1.82% | 520.64M | — | -4.09% |
| RLMD | Relmada Therapeutics, Inc. | 4.80 | -2.83% | 518.16M | — | 2.28% |
| XOMA | XOMA Royalty Corp. | 40.17 | 0.00% | 503.77M | 24.3 | 51.07% |
| VALN | Valneva SE | 5.30 | 0.46% | 496.81M | — | -39.91% |
| KYTX | Kyverna Therapeutics, Inc. | 8.07 | 1.38% | 483.93M | — | -15.32% |
| PRTA | Prothena Corporation plc | 8.58 | -2.03% | 458.61M | — | -8.27% |
| CABA | Cabaletta Bio, Inc. | 2.79 | -0.18% | 454.92M | — | 27.40% |
| DBVT | DBV Technologies S.A. | 14.33 | 6.31% | 454.65M | — | -29.68% |
| PBYI | Puma Biotechnology, Inc. | 8.81 | -1.12% | 453.51M | 16.6 | 49.75% |
| RZLT | Rezolute, Inc. | 4.73 | 0.85% | 451.61M | — | 98.73% |
| BIOA | BioAge Labs Inc. | 11.41 | -2.65% | 441.25M | — | -11.41% |
| XFOR | X4 Pharmaceuticals, Inc. | 4.43 | -4.42% | 437.64M | — | 16.00% |
| OCGN | Ocugen, Inc. | 1.28 | 0.39% | 434.06M | — | -5.19% |
| ASMB | Assembly Biosciences, Inc. | 26.66 | -0.09% | 424.02M | — | -21.55% |
| AVIR | Atea Pharmaceuticals, Inc. | 5.08 | -3.24% | 420.14M | — | 47.06% |
| ABEO | Abeona Therapeutics Inc. | 7.16 | -1.10% | 412.64M | 5.6 | 37.38% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | 4.68 | -2.71% | 377.69M | — | -51.56% |
| KROS | Keros Therapeutics, Inc. | 10.82 | -2.96% | 356.78M | — | -45.24% |
| IRD | Opus Genetics, Inc. | 3.76 | 2.74% | 302.19M | — | 82.09% |
| VNDA | Vanda Pharmaceuticals Inc. | 4.97 | -0.50% | 300.68M | — | -43.31% |
| AMRN | Amarin Corporation plc | 14.31 | -0.35% | 297.00M | — | 2.87% |
| EBS | Emergent BioSolutions Inc. | 4.55 | -5.89% | 249.73M | — | -60.84% |
| CAPR | Capricor Therapeutics, Inc. | 3.85 | -5.87% | 235.22M | — | -85.83% |
| GLSI | Greenwich LifeSciences, Inc. | 15.50 | 7.94% | 210.78M | — | -31.65% |
| VRXA | Veraxa Biotech Holding AG | 1.91 | -4.02% | 55.66M | — | -85.79% |